<DOC>
	<DOCNO>NCT01552837</DOCNO>
	<brief_summary>The aim study determine pharmacological induced equivalent neurogenesis synaptic sprout hippocampus , localize volume change , change water content neurochemical change medial temporal region .</brief_summary>
	<brief_title>Effects Quetiapine Ultrastructural Hippocampal Neurochemical Changes Patients With Bipolar Disorder : Searching Antidepressant Mood Stabilising Neurophysiology</brief_title>
	<detailed_description>Quetiapine antipsychotic mood stabilize antidepressant effect ( Vieta , 2005 ) . Animal study show expression neurotrophins subsequent modulation neuroplastic process , include neurogenesis hippocampus , play key role mechanism mood stabilize ( Kim et al. , 2004 ) antidepressant ( Santarelli et al. , 2003 ) . Since atypical antipsychotic also antidepressant mood stabilize effect , hypothesize common mechanism action three pharmacological class neurogenesis synaptic sprout hippocampal region . Thus , aim study test hypothesis . Quetiapine associate antidepressant mood stabilize effect patient bipolar disorder ( Vieta , 2005 ) . The evidence base animal study show administration quetiapine attenuate decrease level brain-derived neurotrophic factor hippocampus . This may explain improved cognitive symptom patient schizophrenia depression ( Luo et al. , 2005 , Park et al , 2006 ) . The aim study determine pharmacological induced equivalent neurogenesis synaptic sprout hippocampus , localize volume change , change water content neurochemical change medial temporal region .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>age range 18 55 year old intelligence coefficient ( IQ ) minimum 85 estimate MWTB MRI compatibility healthy volunteer DSMIV diagnosis patient diagnosis bipolar disorder accordance DSMIV . substance alcohol abuse dependence ( except caffeine nicotine ) enrollment ; medical condition would affect absorption , distribution , metabolism excretion study treatment ; unstable inadequately treat medical illness ( diabetes , angina , pectoris , hypertension ) ; diabetes mellitus patient opinion investigator pose risk suicide danger self others , patient know intolerance lack response Quetiapine fumarate , patient use cytochrome P450 3A4 inhibitor ( ketoconazole , itraconazole , nelfinavir , ritonavir , fluvoxamine saquinavir ) 14 day precede enrollment , patient use cytochrome P450 inducer ( phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort glucocorticoid ) 14 day precede enrollment , current treatment Quetiapine use mood stabilizer antidepressant comedication throughout study . lack inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Diffusion Tensor Imaging ,</keyword>
	<keyword>quetiapine</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>hippocampus</keyword>
	<keyword>Volume Brain Morphometry</keyword>
	<keyword>Magnetic Resonance Spectroscopy</keyword>
	<keyword>effect quetiapine hippocampal neurogenesis</keyword>
</DOC>